Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902252 · ClinicalTrials.gov registry record · Phase 3
Multi-National Phase III Vitala™ 12-Hour Wear Test
A Phase 3 study, sponsored by ConvaTec.
- Completed
- Registry status
- Phase 3
- Development phase
- 78
- Enrollment target
NCT00902252 is a Phase 3 study that has completed, run by ConvaTec. The registered enrollment target is 78 participants.
The verdict
NCT00902252, a Phase 3 study, has completed, sponsored by ConvaTec.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to demonstrate that the Vitala™ Continence Control Device is both safe and effective when worn up to 12 hours per day.
Interventions
- DEVICE Usual
- DEVICE Natura®
- DEVICE Vitala™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00902252
The ClinicalTrials.gov registry entry for NCT00902252 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ConvaTec, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual is the first listed.
NCT00902252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00902252 about?
NCT00902252 is a clinical study titled "Multi-National Phase III Vitala™ 12-Hour Wear Test". The purpose of this clinical study is to demonstrate that the Vitala™ Continence Control Device is both safe and effective when worn up to 12 hours per day.
What is the current status of trial NCT00902252?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 78 participants. The study started on 2009-04. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00902252?
The interventions under investigation include: Usual (DEVICE), Natura® (DEVICE), Vitala™ (DEVICE).
Who is sponsoring clinical trial NCT00902252?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.